Established in 1982 to work in manufacturing & exporting of branded & generic pharmaceuticals & specially for heart & kidney treatment, one of the major producers under license of merz, Bristol myers squibb, Novartis, Solvany, Mundi Pharma, Hwers, May loy. Subject is considered among the highest 100 tax payers during 2008[according to Ministry of Finance]. Subject is considered among the top, 400 local importers during 2008, & enjoy a good reputation a according to ranking of the Egyptian Customs Authority. 500000000 EGP 500000000 EGP 1000000000 EGP 969357907 EGP 221697 Cairo Joint Stock Private Inv. Law